Literature DB >> 12739001

Effects of overexpression of the Ets family transcription factor TEL on cell growth and differentiation of K562 cells.

Takuya Sakurai1, Toshiyuki Yamada, Fumiko Kihara-Negishi, Sayaka Teramoto, Yuko Sato, Tetsuya Izawa, Tsuneyuki Oikawa.   

Abstract

Functional roles of several Ets transcription factors in megakaryocytic and erythroid differentiation of the human chronic myelogenous leukemia cell line K562 was investigated. When K562 cells were induced to differentiate into the megakaryocyte lineage by treatment with TPA, the expression of the c-ets-1, Fli-1 and TEL2 genes was increased, and that of the TEL gene was decreased at the onset of differentiation. When the cells were induced to differentiate into the erythroid lineage by treatment with Hemin, expression of the c-ets-1 gene was increased, and that of the Fli-1 and TEL genes was decreased. To investigate the role of TEL in the growth and differentiation of K562 cells, we introduced an expression plasmid containing the TEL gene into the cells. Overexpression of TEL in K562 cells leads to inhibition of the endogenous expression of megakaryocyte-specific GPIIb and GPIbalpha genes, and inhibition of cell growth. DNA array analysis revealed that expression of genes such as the RhoG and D4-GDI genes was down-regulated in TEL-overexpressing cells, while that of the representative growth-related genes such as the c-myc, c-fos and c-jun genes was not remarkably changed. These results suggest that several Ets family transcription factors are implicated in megakaryocytic and erythroid differentiation of K562 cells and TEL inhibits the expression of some megakaryocyte-specific genes and growth in K562 cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12739001

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

Review 1.  ETV6 in hematopoiesis and leukemia predisposition.

Authors:  Hanno Hock; Akiko Shimamura
Journal:  Semin Hematol       Date:  2017-04-07       Impact factor: 3.851

Review 2.  Megakaryocyte biology and related disorders.

Authors:  Liyan Pang; Mitchell J Weiss; Mortimer Poncz
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 3.  Differentiation therapy of leukemia: 3 decades of development.

Authors:  Daniel Nowak; Daphne Stewart; H Phillip Koeffler
Journal:  Blood       Date:  2009-02-12       Impact factor: 22.113

4.  Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema.

Authors:  Guillaume Pare; Michiaki Kubo; James B Byrd; Catherine A McCarty; Alencia Woodard-Grice; Koon K Teo; Sonia S Anand; Rebecca L Zuvich; Yuki Bradford; Stephanie Ross; Yusuke Nakamura; Marylyn Ritchie; Nancy J Brown
Journal:  Pharmacogenet Genomics       Date:  2013-09       Impact factor: 2.089

Review 5.  Genetics of Hereditary Angioedema Revisited.

Authors:  Anastasios E Germenis; Matthaios Speletas
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

6.  Germline variants in ETV6 underlie reduced platelet formation, platelet dysfunction and increased levels of circulating CD34+ progenitors.

Authors:  Marjorie Poggi; Matthias Canault; Marie Favier; Ernest Turro; Paul Saultier; Dorsaf Ghalloussi; Veronique Baccini; Lea Vidal; Anna Mezzapesa; Nadjim Chelghoum; Badreddine Mohand-Oumoussa; Céline Falaise; Rémi Favier; Willem H Ouwehand; Mathieu Fiore; Franck Peiretti; Pierre Emmanuel Morange; Noémie Saut; Denis Bernot; Andreas Greinacher; Nihr BioResource; Alan T Nurden; Paquita Nurden; Kathleen Freson; David-Alexandre Trégouët; Hana Raslova; Marie-Christine Alessi
Journal:  Haematologica       Date:  2016-09-23       Impact factor: 9.941

7.  A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma.

Authors:  Chunmei Guo; Chao Gao; Dongting Zhao; Jiahui Li; Jinxia Wang; Xujuan Sun; Qinlong Liu; Lihong Hao; Frederick T Greenaway; Yuxiang Tian; Shuqing Liu; Ming-Zhong Sun
Journal:  J Exp Clin Cancer Res       Date:  2020-04-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.